HCA
Income statement / Annual
Last year (2023), HCA Healthcare, Inc.'s total revenue was $64.97 B,
an increase of 7.86% from the previous year.
In 2023, HCA Healthcare, Inc.'s net income was $5.24 B.
See HCA Healthcare, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$64.97 B
|
$60.23 B
|
$58.75 B
|
$51.53 B
|
$51.34 B
|
$46.68 B
|
$43.61 B
|
$41.49 B
|
$39.68 B
|
$36.92 B
|
| Cost of Revenue |
$9.90 B |
$9.37 B |
$9.48 B |
$8.37 B |
$8.48 B |
$7.72 B |
$7.32 B |
$6.93 B |
$6.64 B |
$6.26 B |
| Gross Profit |
$55.07 B |
$50.86 B |
$49.27 B |
$43.16 B |
$42.86 B |
$38.95 B |
$36.30 B |
$34.56 B |
$33.04 B |
$30.66 B |
| Gross Profit Ratio |
0.85 |
0.84 |
0.84 |
0.84 |
0.83 |
0.83 |
0.83 |
0.83 |
0.83 |
0.83 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$29.49 B
|
$27.69 B
|
$26.78 B
|
$23.87 B
|
$23.56 B
|
$21.43 B
|
$20.06 B
|
$18.90 B
|
$18.12 B
|
$16.64 B
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$29.49 B
|
$27.69 B
|
$26.78 B
|
$23.87 B
|
$23.56 B
|
$21.43 B
|
$20.06 B
|
$18.90 B
|
$18.12 B
|
$16.64 B
|
| Other Expenses |
$0.00 |
$14.12 B |
$12.81 B |
$12.03 B |
$12.08 B |
$10.89 B |
-$466.00 M |
-$430.00 M |
$0.00 |
$0.00 |
| Operating Expenses |
$45.44 B |
$41.81 B |
$39.59 B |
$35.90 B |
$35.64 B |
$32.31 B |
$30.24 B |
$28.36 B |
$27.08 B |
$25.09 B |
| Cost And Expenses |
$55.34 B |
$51.18 B |
$49.07 B |
$44.27 B |
$44.12 B |
$40.04 B |
$37.56 B |
$35.29 B |
$33.71 B |
$31.35 B |
| Interest Income |
$0.00 |
$1.74 B |
$1.57 B |
$1.58 B |
$1.82 B |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1.94 B |
$1.74 B |
$1.57 B |
$1.58 B |
$1.82 B |
$1.76 B |
$1.69 B |
$1.71 B |
$1.67 B |
$1.74 B |
| Depreciation &
Amortization |
$3.08 B
|
$2.97 B
|
$2.85 B
|
$2.72 B
|
$2.60 B
|
$2.28 B
|
$2.13 B
|
$1.97 B
|
$1.90 B
|
$1.82 B
|
| EBITDA |
$12.72 B
|
$13.29 B
|
$14.25 B
|
$9.74 B
|
$9.66 B
|
$9.37 B
|
$8.20 B
|
$8.48 B
|
$7.53 B
|
$7.04 B
|
| EBITDA Ratio |
0.2 |
0.2 |
0.22 |
0.19 |
0.19 |
0.19 |
0.19 |
0.2 |
0.2 |
0.2 |
| Operating Income Ratio
|
0.15
|
0.15
|
0.17
|
0.14
|
0.14
|
0.14
|
0.14
|
0.15
|
0.15
|
0.15
|
| Total Other
Income/Expenses Net |
-$1.92 B
|
-$473.00 M
|
$155.00 M
|
-$1.83 B
|
-$1.97 B
|
-$1.31 B
|
-$1.68 B
|
-$1.39 B
|
-$1.96 B
|
-$1.96 B
|
| Income Before Tax |
$7.71 B |
$8.58 B |
$9.83 B |
$5.43 B |
$5.24 B |
$5.34 B |
$4.38 B |
$4.81 B |
$3.96 B |
$3.48 B |
| Income Before Tax Ratio
|
0.12
|
0.14
|
0.17
|
0.11
|
0.1
|
0.11
|
0.1
|
0.12
|
0.1
|
0.09
|
| Income Tax Expense |
$1.62 B |
$1.75 B |
$2.11 B |
$1.04 B |
$1.10 B |
$946.00 M |
$1.64 B |
$1.38 B |
$1.26 B |
$1.11 B |
| Net Income |
$5.24 B |
$5.64 B |
$6.96 B |
$3.75 B |
$3.51 B |
$3.79 B |
$2.22 B |
$2.89 B |
$2.13 B |
$1.88 B |
| Net Income Ratio |
0.08 |
0.09 |
0.12 |
0.07 |
0.07 |
0.08 |
0.05 |
0.07 |
0.05 |
0.05 |
| EPS |
19.24 |
19.44 |
21.51 |
11.1 |
10.27 |
11.04 |
6.33 |
7.8 |
5.34 |
4.46 |
| EPS Diluted |
18.96 |
19.15 |
21.16 |
10.93 |
10.07 |
10.66 |
5.95 |
7.3 |
4.99 |
4.16 |
| Weighted Average Shares
Out |
$272.40 M
|
$290.35 M
|
$323.32 M
|
$338.27 M
|
$341.21 M
|
$342.90 M
|
$350.09 M
|
$370.54 M
|
$398.74 M
|
$420.48 M
|
| Weighted Average Shares
Out Diluted |
$276.41 M
|
$294.67 M
|
$328.75 M
|
$343.61 M
|
$348.23 M
|
$355.30 M
|
$372.22 M
|
$395.85 M
|
$426.72 M
|
$450.35 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
